Showing 2881-2890 of 3223 results for "".
- Adverum Biotechnologies Announces New INFINITY Phase 2 Trial for DME Drug Candidatehttps://modernod.com/news/adverum-biotechnologies-announces-new-infinity-phase-2-trial-for-dme-drug-candidate/2477842/Adverum Biotechnologies announced the initiation of INFINITY, a phase 2, multicenter, randomized, double-masked, active comparator-controlled trial to assess a single intravitreal (IVT) injection of ADVM-022 in patients with diabetic macular edema (DME). The company also reported financial resul
- Ophthalmologist Shares Experience Implementing Drive-Through IOP Checks Into Practicehttps://modernod.com/news/ophthalmologist-shares-experience-implementing-drive-through-iop-checks-into-practice/2477836/While many eye care practices remain open only for emergent and urgent care, and others slowly reopening with many patients staying at home during the COVID-19 pandemic, providers are exploring alternate ways to maintain the health of patients with chronic conditions such as glaucoma. One intrigu
- Mynosys Changes Name to Centricity Vision; Names New Leadership Teamhttps://modernod.com/news/mynosys-changes-name-to-centricity-vision-names-new-leadership-team/2477834/Centricity Vision, formerly known as Mynosys Cellular Devices, announced a new executive leadership team, along with a new company name. Centricity Vision reflects the company’s core competency, embodied by its Zepto Precision Cataract Surgery Platform, in creating precise, consistent, vis
- Politics Around Hydroxychloroquine Hamper Sciencehttps://modernod.com/news/politics-around-hydroxychloroquine-hamper-science/2477807/Publicity around the drug hydroxychloroquine spiked this week when President Donald Trump revealed that he’s taking it to prevent COVID-19. All the attention on the drug in recent months is increasingly spilling into science, and making it harder for some researchers to actually study wheth
- Inovio Hints at Positive Early Phase 1 Safety Data for COVID-19 Vaccine INO-4800https://modernod.com/news/inovio-hints-at-positive-early-phase-1-safety-data-for-covid-19-vaccine-ino-4800/2477810/Inovio Pharmaceuticals suggested that preliminary safety data from an ongoing phase 1 trial indicates that its experimental COVID-19 DNA vaccine candidate INO-4800 appears to be safe in humans. “We are already seeing safety data and it has been benign,” commented R&D head K
- Three States Will Use Apple-Google Contact Tracing Technology for Virus Tracking Appshttps://modernod.com/news/three-states-will-use-apple-google-contact-tracing-technology-for-virus-tracking-apps/2477806/Alabama, North Dakota and South Carolina are the first states to commit publicly to using Apple and Google’s contact tracing technology in statewide apps meant to slow the spread of coronavirus, according to a CNBC
- Roche Antibody Test for COVID-19 Goes Live at More Than 20 Initial Lab Sites in the UShttps://modernod.com/news/roche-antibody-test-for-covid-19-goes-live-at-more-than-20-initial-lab-sites-in-the-us/2477797/Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab sites throughout the United States, with plans in the next several weeks to increase to more than 200 commercial and hospital lab sites with the ability t
- Avellino Announces A.C.T.S. Program to Help Eye Care and Other Surgical Practices Protect Patients and Staff From COVID-19https://modernod.com/news/avellino-announces-a-c-t-s-program-to-help-eye-care-and-other-surgical-practices-protect-patients-and-staff-from-covid-19/2477792/Avellino announced the rollout of the new A.C.T.S. Program (Active Coronavirus Testing & Safety) designed to help ophthalmology and other elective surgery and procedure-oriented practices safely reopen and resume care while protecting patients and staff from COVID-19 virus transmission. <
- EyePoint Pharmaceuticals Presents Data Showcasing Dexycu at the ASCRS Virtual Meetinghttps://modernod.com/news/eyepoint-pharmaceuticals-presents-data-showcasing-dexycu-at-the-ascrs-virtual-meeting/2477784/EyePoint Pharmaceuticals announced the presentation of positive retrospective case study data supporting Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammation following ocular surgery. The data were presented in three electronic posters and one oral pape
- NIH to Test Hydroxychloroquine, Azithromycin Combination as Potential COVID-19 Treatmenthttps://modernod.com/news/nih-to-test-hydroxychloroquine-azithromycin-combination-as-potential-covid-19-treatment/2477775/The US National Institutes of Health (NIH) said Thursday that it is launching a clinical trial evaluating the combination of hydroxychloroquine plus azithromycin to treat patients with mild-to-moderate COVID-19 in the US. Anthony Fauci, director of the NIH’s National Institute of Allergy an